Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
All APAC Global
All APAC Global
All APAC Global
All APAC Global
BioVaxys Announces Appointment of Policy Advisor 2021-05-20 20:00
BioVaxys And BioElpida Sign Definitive Exclusive Agreement To Begin Ovarian Cancer Vaccine Bioproduction 2021-05-03 20:00
BioVaxys Broadens Intellectual Property Portfolio Commercial Trademark Application Filed for CoviDTH(R) Diagnostic 2021-04-29 20:56
Biovaxys And The World Ovarian Cancer Coalition Join Forces For May 8th, World Ovarian Cancer Day 2021-04-20 20:00
BioVaxys Announces Final Clinical trial results of HPV product from EU partner ProCare Health Iberia published by American Society for Colposcopy and Cervical Pathology 2021-04-14 20:00
BIOVAXYS files FDA pre-IND meeting request and briefing package for COVID-T 2021-03-31 20:00
BioVaxys Enters Agreement With Inotiv To Conduct Preclinical Toxicity Studies For Its Covid-T™ Immunodiagnostic Program 2021-03-18 20:09
BioVaxys Enters Major Bioproduction Agreement With Wuxi Biologics (Hong Kong) Ltd. To Synthesize Proteins For Its SARS-CoV-2 Vaccine And COVID-T™ Immunodiagnostic Programs 2021-03-15 20:00
BioVaxys Expanding Technology Platform To Address Emerging SARS-CoV-2 Variants 2021-03-01 21:00
BioVaxys Announces Appointment To Its Scientific Advisory Board 2021-02-22 21:00
BioVaxys and BioElpida Sign Term Sheet for Clinical Grade BVX-0918A Bio-production 2021-02-18 21:00
BioVaxys and Procare Health Announce Broad Co-Development, Joint Commercialization and Marketing Collaboration for Cancer and Viral Vaccines 2021-02-10 21:26
Covid-T™ Clinical Development Program Initiated Regulatory Advisory Group Engaged 2021-01-28 21:46
BioVaxys Announces Initiation Of Cancer Vaccine EU Clinical Program, Completion Of BVX-0320 Preclinical Program 2021-01-25 21:00
BioVaxys Vaccine Platform Stimulates Robust T-cell Response Against Viral Antigens 2020-12-21 21:00
1 2